Celebrity-backed probiotics startup delays launch of supplement marketed with GLP-1 name

(This sto­ry is from our new Health Tech newslet­ter. If you’d like to sign up, just click here.) 

A gut health start­up with more than $100 mil­lion in fund­ing, a celebri­ty backer and a high-pro­file set of ad­vis­ers is de­lay­ing the launch of a pro­bi­ot­ic prod­uct named “GLP-1 Dai­ly,” tap­ping in on the rise of GLP-1 med­ica­tions used for weight loss. Pen­du­lum Ther­a­peu­tics now says it will wait un­til next year to pre­pare ed­u­ca­tion­al ma­te­ri­als to an­swer ques­tions about how it works.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.